Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083302 · ClinicalTrials.gov registry record · NA
Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 4,385
- Enrollment target
NCT02083302: Completed NA study, sponsored by Rutgers, The State University of New Jersey.
NCT02083302 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 4,385 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (212% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02083302, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,385 participants
- Enrollment target
Study Summary
The purpose of this study was to examine the impact of a bystander intervention education program on college students' attitudes and behaviors associated with bystander intervention and sexual violence.
Primary Outcome
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, \& Moynihan, 2005; see McMahon et al., in press, for scale development information). Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander intentions were assessed via (1) a paper survey in June, July or Augu
Interventions
- BEHAVIORAL SCREAM Theater Dose 1
- BEHAVIORAL SCREAM Theater Doses 2 & SCREAM Theater Dose 3
- BEHAVIORAL SCREAM Theater Dose 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,385 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-02 |
| Phase | NA |
What the finished NCT02083302 record still lists
NCT02083302 is an interventional study that assigns participants to a tested intervention. Its 4,385 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (212% higher).
The record links to 0 conditions, and to 3 interventions - of which SCREAM Theater Dose 1 is the first listed.
NCT02083302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02083302 about?
NCT02083302 is a clinical study titled "Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention". The purpose of this study was to examine the impact of a bystander intervention education program on college students' attitudes and behaviors associated with bystander intervention and sexual violence.
What is the current status of trial NCT02083302?
This trial is currently completed. It is a NA study. The enrollment target is 4,385 participants. The study started on 2010-06. Estimated completion is 2012-02.
What interventions are being tested in trial NCT02083302?
The interventions under investigation include: SCREAM Theater Dose 1 (BEHAVIORAL), SCREAM Theater Doses 2 & SCREAM Theater Dose 3 (BEHAVIORAL), SCREAM Theater Dose 4 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02083302?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02083302's enrollment target sits among peer trials
4,385 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT02660645 · 4,400 participants
Blue Light Cystoscopy With Cysview® Registry
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia